戻る
Jiangsu Recbio Technology Co., Ltd. (02179.HK)価格
02179.HK 株価推移チャート
RECBIO-B (02179.HK)
Jiangsu Recbio Technology Co., Ltd.
HK$5.7
3.63%
$0.2
休場: Jan 16, 16:00:00 HKT
主要データ
前終値
$5.48
始値
$5.5
当日レンジ
$5.48 - $5.7
52週レンジ
$3.4 - $9.8
取引高
11.0K
平均取引高
44.4K
1株当たり利益(TTM)
-1.51
配当利回り
--
時価総額
$1.8B
RECBIO-Bとは何ですか？
Jiangsu Recbio Technology Co., Ltd. engages in the research and development of vaccines. The company is headquartered in Taizhou, Jiangsu and currently employs 507 full-time employees. The company went IPO on 2022-03-31. The firm is still in the research and development stage. The firm's vaccine pipeline includes recombinant human papillomavirus (HPV) 9-valent vaccine, novel adjuvanted recombinant HPV 9-valent vaccine, recombinant HPV bivalent (Types 16/18) vaccine, recombinant HPV bivalent (Types 6/11) vaccine, novel adjuvanted recombinant HPV quadrivalent vaccine, novel adjuvanted recombinant shingles vaccine, novel adjuvanted recombinant respiratory syncytial virus vaccine, recombinant metapneumovirus vaccine, recombinant human cytomegalovirus vaccine, recombinant bicomponent COVID-19 vaccine, recombinant hepatitis B virus vaccine, and others.